Agilon Health, Inc. (NYSE: AGL) Stock Competitors & Peer Comparison
See AGL's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for AGL and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AGL | $92.66 | -6.54% | 1.6B | -9.13 | -$10.22 | N/A |
| HCA | $408.18 | -2.39% | 90.6B | 14.10 | $28.96 | +0.74% |
| THC | $257.62 | -1.91% | 22.2B | 14.95 | $17.24 | N/A |
| DVA | $240.96 | +0.63% | 15.5B | 20.54 | $11.73 | N/A |
| SOLV | $88.55 | +2.76% | 15.3B | 14.19 | $6.24 | N/A |
| FMS | $24.86 | +0.44% | 13.4B | 9.87 | $2.52 | +3.47% |
| EHC | $113.80 | -1.92% | 11.3B | 20.00 | $5.69 | +0.67% |
| ENSG | $181.89 | -0.68% | 10.6B | 26.36 | $6.90 | +0.14% |
| UHS | $168.16 | +1.17% | 10.2B | 7.45 | $22.54 | +0.48% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
AGL vs HCA Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, HCA has a market cap of 90.6B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while HCA trades at $408.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas HCA's P/E ratio is 14.10. In terms of profitability, AGL's ROE is -1.46%, compared to HCA's ROE of -1.13%. Regarding short-term risk, AGL is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for AGL.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
AGL vs THC Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, THC has a market cap of 22.2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while THC trades at $257.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas THC's P/E ratio is 14.95. In terms of profitability, AGL's ROE is -1.46%, compared to THC's ROE of +0.51%. Regarding short-term risk, AGL is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for AGL.Check THC's competition here
DaVita Inc. (NYSE: DVA)
AGL vs DVA Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, DVA has a market cap of 15.5B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while DVA trades at $240.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas DVA's P/E ratio is 20.54. In terms of profitability, AGL's ROE is -1.46%, compared to DVA's ROE of -1.33%. Regarding short-term risk, AGL is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for AGL.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
AGL vs SOLV Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, SOLV has a market cap of 15.3B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while SOLV trades at $88.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas SOLV's P/E ratio is 14.19. In terms of profitability, AGL's ROE is -1.46%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, AGL is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for AGL.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
AGL vs FMS Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, FMS has a market cap of 13.4B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while FMS trades at $24.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas FMS's P/E ratio is 9.87. In terms of profitability, AGL's ROE is -1.46%, compared to FMS's ROE of +0.07%. Regarding short-term risk, AGL is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for AGL.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
AGL vs EHC Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, EHC has a market cap of 11.3B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while EHC trades at $113.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas EHC's P/E ratio is 20.00. In terms of profitability, AGL's ROE is -1.46%, compared to EHC's ROE of +0.25%. Regarding short-term risk, AGL is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for AGL.Check EHC's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
AGL vs ENSG Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while ENSG trades at $181.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas ENSG's P/E ratio is 26.36. In terms of profitability, AGL's ROE is -1.46%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, AGL is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for AGL.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
AGL vs UHS Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, UHS has a market cap of 10.2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while UHS trades at $168.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas UHS's P/E ratio is 7.45. In terms of profitability, AGL's ROE is -1.46%, compared to UHS's ROE of +0.21%. Regarding short-term risk, AGL is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for AGL.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
AGL vs OSH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas OSH's P/E ratio is -17.65. In terms of profitability, AGL's ROE is -1.46%, compared to OSH's ROE of +4.64%. Regarding short-term risk, AGL is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for AGL.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
AGL vs PACS Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while PACS trades at $46.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas PACS's P/E ratio is 39.49. In terms of profitability, AGL's ROE is -1.46%, compared to PACS's ROE of +0.27%. Regarding short-term risk, AGL is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for AGL.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
AGL vs CHE Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CHE has a market cap of 7.2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CHE trades at $539.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CHE's P/E ratio is 24.99. In terms of profitability, AGL's ROE is -1.46%, compared to CHE's ROE of +0.29%. Regarding short-term risk, AGL is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for AGL.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
AGL vs LHCG Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas LHCG's P/E ratio is 82.83. In terms of profitability, AGL's ROE is -1.46%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, AGL is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for AGL.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
AGL vs LFST Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while LFST trades at $10.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas LFST's P/E ratio is 173.01. In terms of profitability, AGL's ROE is -1.46%, compared to LFST's ROE of +0.02%. Regarding short-term risk, AGL is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for AGL.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
AGL vs CON Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CON has a market cap of 4B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CON trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CON's P/E ratio is 21.94. In terms of profitability, AGL's ROE is -1.46%, compared to CON's ROE of +0.46%. Regarding short-term risk, AGL is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for AGL.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
AGL vs OPCH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, OPCH has a market cap of 3.8B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while OPCH trades at $23.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas OPCH's P/E ratio is 13.91. In terms of profitability, AGL's ROE is -1.46%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, AGL is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for AGL.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
AGL vs NHC Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, NHC has a market cap of 3.6B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while NHC trades at $228.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas NHC's P/E ratio is 32.86. In terms of profitability, AGL's ROE is -1.46%, compared to NHC's ROE of +0.12%. Regarding short-term risk, AGL is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for AGL.Check NHC's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
AGL vs BKD Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, BKD has a market cap of 3.5B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while BKD trades at $14.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas BKD's P/E ratio is -25.63. In terms of profitability, AGL's ROE is -1.46%, compared to BKD's ROE of +401.19%. Regarding short-term risk, AGL is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for AGL.Check BKD's competition here
Amedisys, Inc. (NASDAQ: AMED)
AGL vs AMED Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AMED's P/E ratio is 39.30. In terms of profitability, AGL's ROE is -1.46%, compared to AMED's ROE of +0.11%. Regarding short-term risk, AGL is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
AGL vs ACHC Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, ACHC has a market cap of 2.5B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while ACHC trades at $27.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas ACHC's P/E ratio is 13.74. In terms of profitability, AGL's ROE is -1.46%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, AGL is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for AGL.Check ACHC's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
AGL vs ADUS Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while ADUS trades at $119.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas ADUS's P/E ratio is 18.50. In terms of profitability, AGL's ROE is -1.46%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, AGL is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for AGL.Check ADUS's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
AGL vs MD Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while MD trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas MD's P/E ratio is 12.49. In terms of profitability, AGL's ROE is -1.46%, compared to MD's ROE of +0.20%. Regarding short-term risk, AGL is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for AGL.Check MD's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
AGL vs SGRY Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while SGRY trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas SGRY's P/E ratio is 42.08. In terms of profitability, AGL's ROE is -1.46%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, AGL is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for AGL.Check SGRY's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
AGL vs AVAH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AVAH trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AVAH's P/E ratio is 14.34. In terms of profitability, AGL's ROE is -1.46%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, AGL is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AVAH's competition here
Select Medical Holdings Corporation (NYSE: SEM)
AGL vs SEM Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas SEM's P/E ratio is 15.43. In terms of profitability, AGL's ROE is -1.46%, compared to SEM's ROE of +0.08%. Regarding short-term risk, AGL is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for AGL.Check SEM's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
AGL vs AMEH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AMEH's P/E ratio is 39.25. In terms of profitability, AGL's ROE is -1.46%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, AGL is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
AGL vs ASTH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while ASTH trades at $36.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas ASTH's P/E ratio is 24.67. In terms of profitability, AGL's ROE is -1.46%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, AGL is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for AGL.Check ASTH's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
AGL vs HCSG Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while HCSG trades at $23.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas HCSG's P/E ratio is 18.74. In terms of profitability, AGL's ROE is -1.46%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, AGL is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for AGL.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
AGL vs ARDT Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while ARDT trades at $10.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas ARDT's P/E ratio is 6.66. In terms of profitability, AGL's ROE is -1.46%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, AGL is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for AGL.Check ARDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
AGL vs INNV Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while INNV trades at $11.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas INNV's P/E ratio is -127.44. In terms of profitability, AGL's ROE is -1.46%, compared to INNV's ROE of -0.09%. Regarding short-term risk, AGL is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for AGL.Check INNV's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
AGL vs CMPS Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CMPS has a market cap of 1.5B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CMPS trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CMPS's P/E ratio is -5.32. In terms of profitability, AGL's ROE is -1.46%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, AGL is more volatile compared to CMPS. This indicates higher risk in terms of short-term price fluctuations for AGL.Check CMPS's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
AGL vs PNTG Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while PNTG trades at $41.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas PNTG's P/E ratio is 33.40. In terms of profitability, AGL's ROE is -1.46%, compared to PNTG's ROE of +0.09%. Regarding short-term risk, AGL is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for AGL.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
AGL vs AMN Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AMN trades at $34.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AMN's P/E ratio is 11.51. In terms of profitability, AGL's ROE is -1.46%, compared to AMN's ROE of -0.05%. Regarding short-term risk, AGL is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
AGL vs BKDT Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas BKDT's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, AGL is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for AGL.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
AGL vs USPH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while USPH trades at $79.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas USPH's P/E ratio is 30.75. In terms of profitability, AGL's ROE is -1.46%, compared to USPH's ROE of +0.00%. Regarding short-term risk, AGL is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for AGL.Check USPH's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
AGL vs NUTX Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, NUTX has a market cap of 966.8M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while NUTX trades at $140.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas NUTX's P/E ratio is 10.86. In terms of profitability, AGL's ROE is -1.46%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, AGL is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for AGL.Check NUTX's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
AGL vs FSHCX Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, FSHCX has a market cap of 906.7M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while FSHCX trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas FSHCX's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to FSHCX's ROE of N/A. Regarding short-term risk, AGL is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for AGL.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALK)
AGL vs TALK Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, TALK has a market cap of 874.4M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while TALK trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas TALK's P/E ratio is 769.91. In terms of profitability, AGL's ROE is -1.46%, compared to TALK's ROE of +0.01%. Regarding short-term risk, AGL is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for AGL.Check TALK's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
AGL vs SNDA Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, SNDA has a market cap of 815.1M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while SNDA trades at $40.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas SNDA's P/E ratio is -7.55. In terms of profitability, AGL's ROE is -1.46%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, AGL is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for AGL.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
AGL vs EHAB Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas EHAB's P/E ratio is -197.14. In terms of profitability, AGL's ROE is -1.46%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, AGL is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for AGL.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
AGL vs GMRS Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, GMRS has a market cap of 593.1M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while GMRS trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas GMRS's P/E ratio is 5.76. In terms of profitability, AGL's ROE is -1.46%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, AGL is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for AGL.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
AGL vs TOIIW Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, TOIIW has a market cap of 490.9M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, AGL's ROE is -1.46%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, AGL is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for AGL.Check TOIIW's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
AGL vs TOI Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, TOI has a market cap of 476.9M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while TOI trades at $4.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas TOI's P/E ratio is -13.25. In terms of profitability, AGL's ROE is -1.46%, compared to TOI's ROE of +3.27%. Regarding short-term risk, AGL is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for AGL.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
AGL vs VMD Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, VMD has a market cap of 446.6M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while VMD trades at $11.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas VMD's P/E ratio is 31.49. In terms of profitability, AGL's ROE is -1.46%, compared to VMD's ROE of +0.11%. Regarding short-term risk, AGL is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for AGL.Check VMD's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
AGL vs MCTA Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas MCTA's P/E ratio is 419.36. In terms of profitability, AGL's ROE is -1.46%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, AGL is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for AGL.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
AGL vs SRTA Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, SRTA has a market cap of 421.4M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while SRTA trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas SRTA's P/E ratio is -34.26. In terms of profitability, AGL's ROE is -1.46%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, AGL is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for AGL.Check SRTA's competition here
Auna S.A. (NYSE: AUNA)
AGL vs AUNA Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AUNA has a market cap of 384.9M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AUNA trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AUNA's P/E ratio is 4.68. In terms of profitability, AGL's ROE is -1.46%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, AGL is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
AGL vs CYH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CYH has a market cap of 382.1M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CYH trades at $2.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CYH's P/E ratio is 3.71. In terms of profitability, AGL's ROE is -1.46%, compared to CYH's ROE of +0.21%. Regarding short-term risk, AGL is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for AGL.Check CYH's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
AGL vs AIRS Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AIRS has a market cap of 307.2M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AIRS trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AIRS's P/E ratio is -145.17. In terms of profitability, AGL's ROE is -1.46%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, AGL is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
AGL vs CSU Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CSU's P/E ratio is 0.67. In terms of profitability, AGL's ROE is -1.46%, compared to CSU's ROE of -0.51%. Regarding short-term risk, AGL is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for AGL.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
AGL vs JYNT Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, JYNT has a market cap of 118.9M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while JYNT trades at $8.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas JYNT's P/E ratio is 83.40. In terms of profitability, AGL's ROE is -1.46%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, AGL is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for AGL.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
AGL vs FVE Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas FVE's P/E ratio is -5.64. In terms of profitability, AGL's ROE is -1.46%, compared to FVE's ROE of -0.15%. Regarding short-term risk, AGL is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for AGL.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
AGL vs KDLYW Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas KDLYW's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, AGL is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for AGL.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
AGL vs BTMD Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, BTMD has a market cap of 90M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while BTMD trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas BTMD's P/E ratio is 4.64. In terms of profitability, AGL's ROE is -1.46%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, AGL is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for AGL.Check BTMD's competition here
DocGo Inc. (NASDAQ: DCGO)
AGL vs DCGO Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, DCGO has a market cap of 64.2M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while DCGO trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas DCGO's P/E ratio is -0.75. In terms of profitability, AGL's ROE is -1.46%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, AGL is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for AGL.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
AGL vs ALR Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas ALR's P/E ratio is -1.11. In terms of profitability, AGL's ROE is -1.46%, compared to ALR's ROE of -0.15%. Regarding short-term risk, AGL is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for AGL.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
AGL vs PARK Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, PARK has a market cap of 35M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while PARK trades at $17.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas PARK's P/E ratio is 24.30. In terms of profitability, AGL's ROE is -1.46%, compared to PARK's ROE of -0.24%. Regarding short-term risk, AGL is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for AGL.Check PARK's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
AGL vs PIII Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, PIII has a market cap of 34.8M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while PIII trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas PIII's P/E ratio is -0.27. In terms of profitability, AGL's ROE is -1.46%, compared to PIII's ROE of +1.85%. Regarding short-term risk, AGL is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for AGL.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
AGL vs IMAC Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas IMAC's P/E ratio is -2.27. In terms of profitability, AGL's ROE is -1.46%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, AGL is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for AGL.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
AGL vs CCEL Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CCEL has a market cap of 28.2M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CCEL trades at $3.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CCEL's P/E ratio is -10.61. In terms of profitability, AGL's ROE is -1.46%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, AGL is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for AGL.Check CCEL's competition here
Cano Health, Inc. (NYSE: CANO-WT)
AGL vs CANO-WT Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, AGL is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for AGL.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
AGL vs AIH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AIH's P/E ratio is -2.78. In terms of profitability, AGL's ROE is -1.46%, compared to AIH's ROE of +1.16%. Regarding short-term risk, AGL is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for AGL.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
AGL vs CANO Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CANO's P/E ratio is -0.01. In terms of profitability, AGL's ROE is -1.46%, compared to CANO's ROE of -1.49%. Regarding short-term risk, AGL is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for AGL.Check CANO's competition here
American Shared Hospital Services (AMEX: AMS)
AGL vs AMS Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AMS has a market cap of 10.5M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AMS trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AMS's P/E ratio is -7.10. In terms of profitability, AGL's ROE is -1.46%, compared to AMS's ROE of -0.06%. Regarding short-term risk, AGL is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AMS's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
AGL vs FPCG Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas FPCG's P/E ratio is 0.09. In terms of profitability, AGL's ROE is -1.46%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, AGL is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for AGL.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
AGL vs FTRP Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas FTRP's P/E ratio is -1.22. In terms of profitability, AGL's ROE is -1.46%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, AGL is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for AGL.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
AGL vs BMGL Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, BMGL has a market cap of 8.9M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while BMGL trades at $5.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas BMGL's P/E ratio is -1.08. In terms of profitability, AGL's ROE is -1.46%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, AGL is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for AGL.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
AGL vs XWEL Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, XWEL has a market cap of 6.5M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while XWEL trades at $1.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas XWEL's P/E ratio is -0.32. In terms of profitability, AGL's ROE is -1.46%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, AGL is more volatile compared to XWEL. This indicates higher risk in terms of short-term price fluctuations for AGL.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
AGL vs MODV Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas MODV's P/E ratio is -0.06. In terms of profitability, AGL's ROE is -1.46%, compared to MODV's ROE of +1.36%. Regarding short-term risk, AGL is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for AGL.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
AGL vs GBNH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas GBNH's P/E ratio is -0.06. In terms of profitability, AGL's ROE is -1.46%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, AGL is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for AGL.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
AGL vs RHE Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas RHE's P/E ratio is -1.79. In terms of profitability, AGL's ROE is -1.46%, compared to RHE's ROE of -0.36%. Regarding short-term risk, AGL is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for AGL.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
AGL vs RHE-PA Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, AGL's ROE is -1.46%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, AGL is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for AGL.Check RHE-PA's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
AGL vs AIDX Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AIDX has a market cap of 2.5M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AIDX trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AIDX's P/E ratio is -0.83. In terms of profitability, AGL's ROE is -1.46%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, AGL is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
AGL vs IMACW Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas IMACW's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, AGL is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for AGL.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
AGL vs NAKAW Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, AGL's ROE is -1.46%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, AGL is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for AGL.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
AGL vs CCM Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, CCM has a market cap of 642.2K. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while CCM trades at $4.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas CCM's P/E ratio is -0.30. In terms of profitability, AGL's ROE is -1.46%, compared to CCM's ROE of +0.06%. Regarding short-term risk, AGL is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for AGL.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
AGL vs NIVF Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, NIVF has a market cap of 159.8K. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while NIVF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas NIVF's P/E ratio is 0.42. In terms of profitability, AGL's ROE is -1.46%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, AGL is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for AGL.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
AGL vs MNDR Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, MNDR has a market cap of 41.1K. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while MNDR trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas MNDR's P/E ratio is -0.04. In terms of profitability, AGL's ROE is -1.46%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, AGL is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for AGL.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
AGL vs NIVFW Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, NIVFW has a market cap of 39.1K. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, AGL's ROE is -1.46%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, AGL is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for AGL.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
AGL vs TALKW Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas TALKW's P/E ratio is 0.00. In terms of profitability, AGL's ROE is -1.46%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, AGL is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for AGL.Check TALKW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
AGL vs TLMDW Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas TLMDW's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, AGL is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for AGL.Check TLMDW's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
AGL vs ATIP-WT Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, AGL is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for AGL.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
AGL vs SLHGP Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, AGL's ROE is -1.46%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, AGL is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for AGL.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
AGL vs SLHG Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas SLHG's P/E ratio is -1.48. In terms of profitability, AGL's ROE is -1.46%, compared to SLHG's ROE of N/A. Regarding short-term risk, AGL is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for AGL.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
AGL vs AFAM Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas AFAM's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, AGL is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for AGL.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
AGL vs TLMD Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas TLMD's P/E ratio is -1.60. In terms of profitability, AGL's ROE is -1.46%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, AGL is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for AGL.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
AGL vs KND Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, KND has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas KND's P/E ratio is -1.14. In terms of profitability, AGL's ROE is -1.46%, compared to KND's ROE of -0.53%. Regarding short-term risk, AGL is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for AGL.Check KND's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
AGL vs DVCR Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas DVCR's P/E ratio is 28.34. In terms of profitability, AGL's ROE is -1.46%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, AGL is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for AGL.Check DVCR's competition here
Hanger, Inc. (NYSE: HNGR)
AGL vs HNGR Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas HNGR's P/E ratio is 19.71. In terms of profitability, AGL's ROE is -1.46%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, AGL is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for AGL.Check HNGR's competition here
New Frontier Health Corporation (NYSE: NFH)
AGL vs NFH Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, NFH has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas NFH's P/E ratio is -19.75. In terms of profitability, AGL's ROE is -1.46%, compared to NFH's ROE of -0.06%. Regarding short-term risk, AGL is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for AGL.Check NFH's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
AGL vs TVTY Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas TVTY's P/E ratio is 19.06. In terms of profitability, AGL's ROE is -1.46%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, AGL is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for AGL.Check TVTY's competition here
DocGo Inc. (NASDAQ: DCGOW)
AGL vs DCGOW Comparison July 2026
Agilon Health, Inc. (NYSE: AGL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AGL stands at 1.6B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, AGL is priced at $92.66 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AGL currently has a P/E ratio of -9.13, whereas DCGOW's P/E ratio is N/A. In terms of profitability, AGL's ROE is -1.46%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, AGL is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for AGL.Check DCGOW's competition here